Home LiteratureArticle Details
PMID: 17872573 Published · ppublish English Consensus Development Conference Journal Article

Advances in counselling and surveillance of patients at risk for pancreatic cancer.

Gut ·Vol. 56 ·No. 10 ·2007-10-00 ·Pages 1460-9

Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI, Participants of the Fourth International Symposium of Inherited Diseases of the Pancreas

Abstract

暂无摘要

MeSH Terms
Early Diagnosis Genetic Counseling/methods Genetic Predisposition to Disease Humans Mass Screening/methods Pancreatic Neoplasms/diagnosis,genetics,prevention & control Population Surveillance/methods Risk Factors
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Brand Randall E
Evanston Northwestern Healthcare, Evanston, Illinois, USA. rbrand@enh.org
Lerch Markus M
Rubinstein Wendy S
Neoptolemos John P
Whitcomb David C
Hruban Ralph H
Brentnall Teresa A
Lynch Henry T
Canto Marcia I
Participants of the Fourth International Symposium of Inherited Diseases of the Pancreas
References (83)
83 references, click to expand
  1. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.
    JAMA. 1995 May 24-31;273(20):1605-9 PMID: 7745774
  2. Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population.
    J Gastroenterol Hepatol. 2004 Feb;19(2):182-6 PMID: 14731128
  3. Cancer Incidence in BRCA1 mutation carriers.
    J Natl Cancer Inst. 2002 Sep 18;94(18):1358-65 PMID: 12237281
  4. Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study.
    J Natl Cancer Inst. 2003 Mar 5;95(5):381-7 PMID: 12618503
  5. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    J Clin Oncol. 2003 Jun 15;21(12):2397-406 PMID: 12692171
  6. Familial risk of pancreatic cancer.
    J Natl Cancer Inst. 2001 Apr 18;93(8):640-4 PMID: 11309441
  7. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.
    J Natl Cancer Inst. 2000 Aug 2;92(15):1260-6 PMID: 10922411
  8. Pancreatitis and the risk of pancreatic cancer.
    Pancreas. 1995 Aug;11(2):185-9 PMID: 7479677
  9. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer.
    Cancer Res. 2005 Jan 15;65(2):383-6 PMID: 15695377
  10. Genetic alterations in pancreatic carcinoma.
    Mol Cancer. 2003 Jan 22;2:15 PMID: 12605716
  11. Ensuring early diagnosis in pancreatic cancer.
    Practitioner. 2000 Apr;244(1609):336-8, 340-1, 343 PMID: 10892054
  12. Genetic progression in the pancreatic ducts.
    Am J Pathol. 2000 Jun;156(6):1821-5 PMID: 10854204
  13. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).
    Int J Cancer. 2000 Sep 15;87(6):809-11 PMID: 10956390
  14. Inherited pancreatic cancer: surveillance and treatment strategies for affected families.
    Pancreatology. 2001;1(5):477-85 PMID: 12120228
  15. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.
    Cancer Res. 2002 Jul 1;62(13):3789-93 PMID: 12097290
  16. Fanconi anemia gene mutations in young-onset pancreatic cancer.
    Cancer Res. 2003 May 15;63(10):2585-8 PMID: 12750283
  17. BRCA2 germline mutations in familial pancreatic carcinoma.
    J Natl Cancer Inst. 2003 Feb 5;95(3):214-21 PMID: 12569143
  18. The prevalence of BRCA2 mutations in familial pancreatic cancer.
    Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):342-6 PMID: 17301269
  19. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.
    J Natl Cancer Inst. 2002 Sep 18;94(18):1365-72 PMID: 12237282
  20. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer.
    Br J Cancer. 1999 Aug;80(11):1830-7 PMID: 10468306
  21. BRCA1 and pancreatic cancer: pedigree findings and their causal relationships.
    Cancer Genet Cytogenet. 2005 Apr 15;158(2):119-25 PMID: 15796958
  22. The risk of pancreatic cancer following pancreatitis: an association due to confounding?
    Gastroenterology. 1997 Aug;113(2):587-92 PMID: 9247480
  23. Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study.
    J Natl Cancer Inst. 2005 Oct 5;97(19):1458-65 PMID: 16204695
  24. Pancreatic cancer in hereditary pancreatitis: consensus guidelines for prevention, screening and treatment.
    Pancreatology. 2001;1(5):416-22 PMID: 12120218
  25. Cancer risks in BRCA2 mutation carriers.
    J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6 PMID: 10433620
  26. Diagnostic and therapeutic approach to pancreatic cancer.
    Biomed Pharmacother. 2000 Aug;54(7):400-9 PMID: 10989980
  27. Pancreatic cancer: state-of-the-art care.
    CA Cancer J Clin. 2000 Jul-Aug;50(4):241-68 PMID: 10986966
  28. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer.
    Ann Intern Med. 1999 Aug 17;131(4):247-55 PMID: 10454945
  29. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds.
    Gastroenterology. 2003 May;124(5):1292-9 PMID: 12730869
  30. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers.
    Am J Pathol. 1999 Jun;154(6):1835-40 PMID: 10362809
  31. The relationship between diabetes and pancreatic cancer.
    Mol Cancer. 2003 Jan 6;2:4 PMID: 12556242
  32. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.
    Ann Surg. 1995 Jun;221(6):721-31; discussion 731-3 PMID: 7794076
  33. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.
    N Engl J Med. 2000 Jul 13;343(2):78-85 PMID: 10891514
  34. Precursors to invasive pancreatic cancer.
    Adv Anat Pathol. 2005 Mar;12(2):81-91 PMID: 15731576
  35. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.
    N Engl J Med. 1993 May 20;328(20):1433-7 PMID: 8479461
  36. Screening and surveillance for hereditary pancreatic cancer.
    Gastrointest Endosc. 2002 Oct;56(4 Suppl):S82-6 PMID: 12297755
  37. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis.
    JAMA. 2001 Jul 11;286(2):169-70 PMID: 11448279
  38. Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.
    J Med Genet. 2005 Sep;42(9):711-9 PMID: 16141007
  39. Symptoms of pancreatic cancer.
    J Pain Symptom Manage. 1991 Aug;6(6):360-7 PMID: 1880437
  40. Pancreatic cancer.
    Lancet. 2004 Mar 27;363(9414):1049-57 PMID: 15051286
  41. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
    Cancer Res. 2000 Jan 15;60(2):409-16 PMID: 10667595
  42. Pancreatitis is a risk factor for pancreatic cancer.
    Gastroenterology. 1995 Jul;109(1):247-51 PMID: 7797022
  43. Hereditary pancreatitis: clinical presentation, ERCP findings, and outcome of endoscopic therapy.
    Gastrointest Endosc. 2002 Jul;56(1):66-71 PMID: 12085037
  44. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.
    Oncogene. 2005 May 19;24(22):3652-6 PMID: 15806175
  45. Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups.
    Gastroenterology. 2005 Jun;128(7):2124-30 PMID: 15940643
  46. Familial pancreatic cancer: clinicopathologic study of 18 nuclear families.
    Am J Gastroenterol. 1990 Jan;85(1):54-60 PMID: 2296965
  47. Alcohol and pancreatic cancer. Insufficient epidemiologic evidence for a causal relationship.
    Epidemiol Rev. 1986;8:28-41 PMID: 3533583
  48. Alcohol, tobacco and coffee consumption and the risk of pancreatic cancer: results from the Canadian Enhanced Surveillance System case-control project. Canadian Cancer Registries Epidemiology Research Group.
    Eur J Cancer Prev. 2000 Feb;9(1):49-58 PMID: 10777010
  49. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family.
    PLoS Med. 2004 Dec;1(3):e65 PMID: 15630470
  50. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group.
    N Engl J Med. 1995 Feb 23;332(8):494-9 PMID: 7830730
  51. Clinical and genetic characteristics of hereditary pancreatitis in Europe.
    Clin Gastroenterol Hepatol. 2004 Mar;2(3):252-61 PMID: 15017610
  52. Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts.
    Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):429-37 PMID: 11352851
  53. Clinicopathological aspects of small pancreatic cancer.
    Pancreas. 2004 Apr;28(3):235-40 PMID: 15084963
  54. Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome.
    Pancreas. 1991 Mar;6(2):127-31 PMID: 1886881
  55. Diabetes and the risk of pancreatic cancer.
    N Engl J Med. 1994 Jul 14;331(2):81-4 PMID: 8208269
  56. Spontaneous and sporadic trypsinogen mutations in idiopathic pancreatitis.
    JAMA. 2002 Nov 6;288(17):2122 PMID: 12413370
  57. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.
    PLoS Med. 2006 Dec;3(12):e516 PMID: 17194196
  58. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
    Clin Gastroenterol Hepatol. 2004 Jul;2(7):606-21 PMID: 15224285
  59. Anticipation in familial pancreatic cancer.
    Gut. 2006 Feb;55(2):252-8 PMID: 15972300
  60. A prospective comparison of current diagnostic tests for pancreatic cancer.
    N Engl J Med. 1977 Oct 6;297(14):737-42 PMID: 895803
  61. Probability of pancreatic cancer following diabetes: a population-based study.
    Gastroenterology. 2005 Aug;129(2):504-11 PMID: 16083707
  62. Incidence of cancer in the course of chronic pancreatitis.
    Am J Gastroenterol. 1999 May;94(5):1253-60 PMID: 10235203
  63. Vitamin D intake and the risk for pancreatic cancer in two cohort studies.
    Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1688-95 PMID: 16985031
  64. Genetic testing for hereditary pancreatitis: guidelines for indications, counselling, consent and privacy issues.
    Pancreatology. 2001;1(5):405-15 PMID: 12120217
  65. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
    N Engl J Med. 1995 Oct 12;333(15):970-4 PMID: 7666916
  66. Physical activity, obesity, height, and the risk of pancreatic cancer.
    JAMA. 2001 Aug 22-29;286(8):921-9 PMID: 11509056
  67. The diagnosis of pancreatic cancer.
    Cancer J. 2001 Jul-Aug;7(4):287-97 PMID: 11561605
  68. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria.
    Br J Cancer. 2005 Oct 31;93(9):1062-7 PMID: 16234822
  69. Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study.
    Br J Cancer. 1985 Aug;52(2):271-3 PMID: 4027169
  70. Endoscopic ultrasonography: changes of chronic pancreatitis in asymptomatic and symptomatic alcoholic patients.
    J Ultrasound Med. 1999 Jul;18(7):455-62 PMID: 10400047
  71. Breast cancer susceptibility genes: current challenges and future promises.
    Ann Intern Med. 1996 Jun 15;124(12):1088-90 PMID: 8633825
  72. Patient perspective on the value of genetic counselling for familial pancreas cancer.
    Hered Cancer Clin Pract. 2005 Aug 15;3(3):115-22 PMID: 20223036
  73. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group.
    J Natl Cancer Inst. 1997 Mar 19;89(6):442-6 PMID: 9091646
  74. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.
    Cancer Res. 2004 Apr 1;64(7):2634-8 PMID: 15059921
  75. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer.
    J Natl Cancer Inst. 2001 Jun 20;93(12):937-41 PMID: 11416115
  76. Imaging of small pancreatic ductal adenocarcinoma.
    Pancreas. 1998 Apr;16(3):396-401 PMID: 9548685
  77. Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists.
    Cancer. 1988 Jun 15;61(12):2578-85 PMID: 3365678
  78. Clinical utility of the serum CA 19-9 test for diagnosing pancreatic carcinoma in symptomatic patients: a prospective study.
    Pancreas. 1992;7(4):497-502 PMID: 1641392
  79. Very high risk of cancer in familial Peutz-Jeghers syndrome.
    Gastroenterology. 2000 Dec;119(6):1447-53 PMID: 11113065
  80. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
    N Engl J Med. 2004 Mar 18;350(12):1200-10 PMID: 15028824
  81. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.
    Clin Gastroenterol Hepatol. 2006 Jun;4(6):766-81; quiz 665 PMID: 16682259
  82. Epidemiology of and risk factors for pancreatic cancer.
    Surg Oncol Clin N Am. 1998 Jan;7(1):67-91 PMID: 9443987
  83. Risk of pancreatic adenocarcinoma in chronic pancreatitis.
    Gut. 2002 Dec;51(6):849-52 PMID: 12427788
Article Info
Journal
Gut
Abbr.
Gut
ISSN
0017-5749
DOI
10.1136/gut.2006.108456
Email
rbrand@enh.org
Published
2007-10-00
Pages
1460-9
Language
English
Region
England
NLM ID
2985108R
PMCID
PMC2000231
Subset
IM
External Links
PubMed source DOI: 10.1136/gut.2006.108456 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2